Name Marc Garidel | ||
 | ||
Marc de Garidel est l'invité de l'X
Marc de Garidel is a French businessman. He serves as the non-executive chairman of the pharmaceutical company Ipsen and advises Mayroy, the Ipsen controlling holding company.
Contents
Early life
Marc de Garidel graduated from the École Spéciale des Travaux Publics, an engineering grandes écoles in Paris. He received business degrees from the Thunderbird School of Global Management in Glendale, Arizona and the Harvard Business School.
Career
In 1983, he started his career at Eli Lilly and Company, where he worked in France, the United States and Germany.
In 1995, he joined Amgen as Vice President, of Finance and Treasury for Europe. In 1998, he became Vice President, Corporate Controller and Chief Accounting Officer of Amgen. In 2000, he became Vice President and General Manager for France, in charge of Amgen France. In 2006, he became Vice President for Southwestern Europe, including France, Spain, Belgium and Portugal. From 2007 to 2010, he served as Vice President for Southern Europe, the Middle East, Asia and Latin America at Amgen.
He has served as Chairman and CEO of Ipsen since November 2010. He sits on the Board of Directors of TcLand Expression. He is also Chairman of the Board of Promethera Biosciences and European Biopharmaceutical Entreprises.
He is President and spokesperson for G5 santé, a lobbying group for French pharmaceutical companies, including BioMérieux, Guerbet, Ipsen, the Laboratoire français du Fractionnement et des Biotechnologies, Laboratoires Pierre Fabre, Sanofi, Stallergenes and Laboratoires Théa.
The Board of Directors of Ipsen has appointed David Meek as Chief Executive Officer, effective July 18,2016. On this date, Marc de Garidel will assume the role of non-executive chairman and will continue to serve the Board of Directors through his deep industry expertise. In addition, Marc de Garidel will advise Mayroy, the Ipsen controlling holding company.
He is a Knight in the National Order of the Legion of Honour.